This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
University of Toronto experts analyzed information from the U.S. FDA's database, pinpointing reasons that errors occurred during thermal ablation procedures.
While the use of ultrasound for pediatric appendicitis imaging has increased, the modality -- as well as MRI -- remains underutilized in this area, according to research published August 22 in the Journal of Pediatric Surgery. A team led by Mark Slidell, MD, from Johns Hopkins University in Baltimore, MD, found that CT remains the most used imaging method for diagnostic pediatric appendicitis in hospitals that don’t participate in the National Surgical Quality Improvement Program - Pediatrics (N
OIA recently collaborated with Atrium Health Wake Forest Baptist to open a new outpatient location in Greensboro, North Carolina’s 3rd most populous city.
The founder of an interventional radiology practice in Houston has agreed to pay $8.8 million to settle an anti-kickback violation case, announced U.S. Attorney Alamdar S. Hamdani in an August 20 statement. According to the claim, beginning in 2015, Andrew Gomes , MD, allegedly offered physicians who invested in his clinics returns in dividends if they referred patients for treatment of peripheral arterial disease (PAD).
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
“Dr. Gomes and [National Interventional Radiology Partners] clearly prioritized greed above the health and well-being of their elderly patients,” an FBI agent charged.
CT shows that soft tissue changes after pancreatic ductal adenocarcinoma (PDAC) surgery suggest local recurrence, researchers have reported. The changes include vessel encasement and luminal narrowing, wrote a team led by Tae-Hyung Kim, MD, of Memorial Sloan Kettering Cancer Center in New York City. Hyung's group found that on surveillance CT exams showing local recurrence after PDAC resection, new or increased soft tissue was present in 80% to 86%.
CT shows that soft tissue changes after pancreatic ductal adenocarcinoma (PDAC) surgery suggest local recurrence, researchers have reported. The changes include vessel encasement and luminal narrowing, wrote a team led by Tae-Hyung Kim, MD, of Memorial Sloan Kettering Cancer Center in New York City. Hyung's group found that on surveillance CT exams showing local recurrence after PDAC resection, new or increased soft tissue was present in 80% to 86%.
Currently in phase III trials, the 64Cu-SAR-bisPSMA PET agent reportedly offers a longer half-life and higher tumor uptake than other radiopharmaceuticals for prostate cancer imaging.
The fiscal year (FY) 2025 Hospital Inpatient Prospective Payment System (IPPS) final rule includes a new technology add-on payment (NTAP) of $241.39 for Annalise.ai's Enterprise CTB Triage - OH, the American College of Radiology (ACR) noted in a final rule summary. Annalise Enterprise CTB Triage - OH is software that uses an AI algorithm to aid in the triage and prioritization of studies with features suggestive of obstructive hydrocephalus (OH) in noncontrast CT (NCCT) brain scans.
tim.hodson Fri, 08/23/2024 - 16:00 Aug. 23, 2024 — Qure.ai recently announced its AI-powered chest CT solution, qCT LN Quant, has received 510(k) FDA clearance. The new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring. qCT LN Quant joins the Qure.ai US AI-powered Lung Cancer care continuum, featuring end-to-end AI solutions to identify, measure, manage,
Cleerly has appointed a new chief technology officer (CTO) and vice president of marketing and has promoted its chief revenue officer (CRO) to chief commercial officer (CCO). Serving as CTO, Steven Borg joins Cleerly from 3motion.ai where he also held that position. Borg previously worked for Microsoft as senior director of health data and AI. David McGovern has become Cleerly's new vice president of marketing.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Researchers have developed an AI program to detect the presence and severity of mitral valve regurgitation from echocardiograms that could help identify patients for a minimally invasive procedure or surgery.
The recent AHRA (Association for Medical Imaging Management) conference in Orlando was a thrilling experience for KMG. It offered a unique platform to explore the latest advancements in medical imaging, and we’re eager to share the top five takeaways that have us excited for the future. 1. AI’s Revolutionary Impact on MRI and CT Imaging […] The post Top 5 Takeaways from AHRA 2024: AI, Remote Scanning, and the Future of Mobile Imaging appeared first on Kings Medical Group.
ACUSON Origin system offers integrated AI for enhanced clinical decision-making System addresses entire continuum of cardiovascular patient care AcuNav Lumos 4D ICE catheter delivers MPR biplane imaging and real-time 4D color Doppler Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ACUSON Origin, a new dedicated cardiovascular ultrasound system powered by artificial intelligence (AI) features.
On Tuesday, August 20, nine students presented their theses in the annual Masters of Science in Biomedical Imaging Symposium at Genentech Hall on the UCSF Mission Bay campus. Celebrating with the MSBI students were eight faculty advisors and department researchers and staff.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
tim.hodson Fri, 08/23/2024 - 08:00 Aug. 21, 2024 — NANO-X IMAGING LTD recently announced that its deep-learning medical imaging analytics subsidiary, Nanox.AI, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for HealthCCSng V2.0. HealthCCSng V2.0 is the upgraded version of Nanox.AI’s cardiac solution, HealthCCSng, which has already shown tangible results in several healthcare systems, identifying patients at high risk of coronary artery disease while driving significan
Researchers have developed an AI program to detect the presence and severity of mitral valve regurgitation from echocardiograms that could help identify patients for a minimally invasive procedure or surgery.
The final preparations for MEDICA 2024 and COMPAMED 2024 trade fairs organized by Messe Düsseldorf have begun with a total of more than 6,000 participants from approximately 70 countries set to fill the entire hall space on the trade fair premises.
ZSFG faculty had an evening of woodworking and fun at Wood Thumb studio in the Mission District. Using reclaimed wood to make cutting boards and magnetic knife racks, everyone found much enjoyment in craftsmanship and socializing.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
In arteriovenous malformation (AVM) consisting of multiple arterioles that shunt into a dominant draining vein, such as Cho Type II/Yakes Type III, occluding the vein can achieve a complete cure (1). However, tortuous vasculature can make catheterization to the embolization target difficult. The authors report that rectal inflation using a balloon device straightened the tortuous draining vein and overcame this hurdle in the embolization of rectal AVM.
To assess compare the efficacy effectiveness and safety of percutaneous microwave ablation (MWA) for subdiaphragmatic versus non-subdiaphragmatic colorectal liver metastasis (CLM).
40
40
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content